Home Cart 0 Sign in  
X

[ CAS No. 22921-68-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 22921-68-2
Chemical Structure| 22921-68-2
Chemical Structure| 22921-68-2
Structure of 22921-68-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 22921-68-2 ]

Related Doc. of [ 22921-68-2 ]

Alternatived Products of [ 22921-68-2 ]

Product Details of [ 22921-68-2 ]

CAS No. :22921-68-2 MDL No. :MFCD00020214
Formula : C8H7BrO3 Boiling Point : -
Linear Structure Formula :- InChI Key :ODHJOROUCITYNF-UHFFFAOYSA-N
M.W : 231.04 Pubchem ID :89906
Synonyms :

Calculated chemistry of [ 22921-68-2 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.59
TPSA : 46.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.72
Log Po/w (XLOGP3) : 2.14
Log Po/w (WLOGP) : 2.16
Log Po/w (MLOGP) : 2.06
Log Po/w (SILICOS-IT) : 1.89
Consensus Log Po/w : 1.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.86
Solubility : 0.32 mg/ml ; 0.00138 mol/l
Class : Soluble
Log S (Ali) : -2.75
Solubility : 0.412 mg/ml ; 0.00178 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.76
Solubility : 0.403 mg/ml ; 0.00175 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.55

Safety of [ 22921-68-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 22921-68-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 22921-68-2 ]
  • Downstream synthetic route of [ 22921-68-2 ]

[ 22921-68-2 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 6313-33-3 ]
  • [ 22921-68-2 ]
  • [ 19181-64-7 ]
YieldReaction ConditionsOperation in experiment
55% With 8-quinolinol; sodium hydroxide; copper dichloride In water at 20℃; for 0.333333 h; Sealed tube; Microwave irradiation General procedure: In a 10 mL glass tube 2-iodobenzoic acid (1.0 mmol), acetamidine hydrochloride (1.2 mmol), CuCl2 (0.1 mmol), L2 (0.1 mmol), and NaOH (4.0 equiv.) and 3.0 mL water were placed. The vessel was then sealed with a septum and placed into the microwave cavity. Initial microwave irradiation of 120 W by using a CEM Discover microwave synthesizer was used at the room temperature for 20 min. The reaction mixture was stirred continuously during the reaction. After completion of the reaction, the solvent was removed in vacuo. The residue was purified by silica gel column chromatography to afford the corresponding product. All the products were confirmed by NMR and MS spectroscopic analysis.
Reference: [1] Synthetic Communications, 2018, vol. 48, # 24, p. 3089 - 3098
  • 2
  • [ 22921-68-2 ]
  • [ 1143-70-0 ]
Reference: [1] ChemMedChem, 2011, vol. 6, # 12, p. 2273 - 2286
[2] RSC Advances, 2017, vol. 7, # 28, p. 17254 - 17263
[3] Patent: US2008/31862, 2008, A1,
  • 3
  • [ 22921-68-2 ]
  • [ 108-46-3 ]
  • [ 1143-70-0 ]
Reference: [1] Patent: WO2014/4902, 2014, A2,
  • 4
  • [ 590-28-3 ]
  • [ 22921-68-2 ]
  • [ 37795-77-0 ]
YieldReaction ConditionsOperation in experiment
61% for 3 h; Heating / reflux 5.00 g (21.6mmol) 2-Bromo-5-methoxy-benzoic acid, 620 mg (4.32mmol) copper (I) bromide and 2.63 g (32.4 mmol) potassium cyanate were dissolved in pyridine and boiled for 30 min. The solvent was removed and the residue was dissolved in 150 ml 2N hydrogen chloride acid and 150 ml ethyl acetate. The organic solvent was treated with water and brine, dried over magnesium sulfate and removed. The residue was digested with methanol. Yield: 2.50 g= 61percent Grey powder
Reference: [1] Patent: WO2008/52742, 2008, A1, . Location in patent: Page/Page column 22; Sheet 4
  • 5
  • [ 22921-68-2 ]
  • [ 19614-12-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4721 - 4736
  • 6
  • [ 22921-68-2 ]
  • [ 6342-63-8 ]
Reference: [1] Chemische Berichte, 1987, vol. 120, p. 1151 - 1174
[2] Angewandte Chemie - International Edition, 2013, vol. 52, # 29, p. 7509 - 7513[3] Angew. Chem., 2013, vol. 125, # 29, p. 7657 - 7661,5
[4] Chinese Chemical Letters, 2015, vol. 26, # 10, p. 1231 - 1235
  • 7
  • [ 75-16-1 ]
  • [ 22921-68-2 ]
  • [ 6342-63-8 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 1, p. 80 - 83
  • 8
  • [ 22921-68-2 ]
  • [ 2612-02-4 ]
Reference: [1] Patent: US7335791, 2008, B1, . Location in patent: Page/Page column 20-21
  • 9
  • [ 22921-68-2 ]
  • [ 7507-86-0 ]
Reference: [1] Journal of the American Chemical Society, 2002, vol. 124, # 7, p. 1354 - 1363
[2] Journal of Organic Chemistry, 1993, vol. 58, # 17, p. 4579 - 4583
[3] Journal of the American Chemical Society, 2011, vol. 133, # 20, p. 7916 - 7925
[4] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 149 - 162
[5] Chemistry - An Asian Journal, 2018, vol. 13, # 17, p. 2401 - 2404
  • 10
  • [ 22921-68-2 ]
  • [ 71-43-2 ]
  • [ 60080-98-0 ]
Reference: [1] European Journal of Organic Chemistry, 2014, vol. 2014, # 7, p. 1423 - 1430
[2] European Journal of Organic Chemistry, 2014, vol. 2014, # 7, p. 1423 - 1430
  • 11
  • [ 22921-68-2 ]
  • [ 60080-98-0 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 12, p. 2695 - 2711
[2] Organic and Biomolecular Chemistry, 2013, vol. 11, # 42, p. 7262 - 7266
  • 12
  • [ 22921-68-2 ]
  • [ 58380-11-3 ]
YieldReaction ConditionsOperation in experiment
4.2 g With aluminum (III) chloride In chlorobenzene for 2.5 h; Reflux 2-Bromo-5-methoxybenzoic acid5 g (manufactured by Wako Pure Chemical Industries, Ltd.) and 15 g of aluminum chloride were refluxed in 150 mL of chlorobenzene for 2.5 hours.After cooling, the reaction solution was transferred to ice water and extracted three times with 250 mL of diethyl ether. The obtained extract was concentrated under reduced pressure, diethyl ether was distilled off,4.2 g of 2-bromo-5-hydroxybenzoic acid was obtained.3.9 g of the obtained 2-bromo-5-hydroxybenzoic acid and 3.9 g of resorcinol (Tokyo Chemical Industry Co., Ltd.) were dissolved in 9 mL of 4 M NaOH aqueous solution at 60 ° C.,And heated for 30 minutes. To this reaction solution was added 1.8 mL of a 10percent aqueous solution of copper sulfate,Further,Heating was carried out for 10 minutes.The precipitate formed was collected by filtration,A white powder of urolitin A was obtained.
4.2 g With aluminum (III) chloride In chlorobenzene for 2.5 h; Reflux 5g of 2-bromo-5-methoxybenzoic acid (manufactured by Wako Pure Chemical Industries, Ltd.) and 15 g of aluminum chloride were refluxed in 150 mL of chlorobenzene for 2.5 hours. After cooling, the reaction solution was transferred to ice water and extracted three times with 250 mL of diethyl ether. The obtained extract was concentrated under reduced pressure and diethyl ether was distilled off to obtain 4.2 g of 2-bromo-5-hydroxybenzoic acid. 3.9 g of the obtained 2-bromo-5-hydroxybenzoic acid and 3.9 g of resorcinol (Tokyo Chemical Industry Co., Ltd.) were heated in 9 mL of 4 M NaOH aqueous solution at 60 ° C. for 30 minutes. 1.8 mL of a 10percent aqueous solution of copper sulfate was added to the reaction solution, followed by further heating at 80 ° C. for 10 minutes. The precipitate formed was recovered by filtration to obtain a white powder of urolitin A.
4.2 g With aluminum (III) chloride In chlorobenzene for 2.5 h; Reflux 5 g of 2-bromo-5-methoxybenzoic acid (manufactured by Wako Pure Chemical Industries, Ltd.) and 15 g of aluminum chloride were refluxed in 150 mL of chlorobenzene for 2.5 hours.After cooling,The reaction solution was transferred to ice water,Extraction was carried out three times with 250 mL of diethyl ether.The obtained extract was concentrated under reduced pressure, diethyl ether was distilled off,4.2 g of 2-bromo-5-hydroxybenzoic acid was obtained.
4.2 g With aluminum (III) chloride In chlorobenzene for 2.5 h; Reflux 5 g of 2-bromo-5-methoxybenzoic acid (manufactured by Wako Pure Chemical Industries, Ltd.) and 15 g of aluminum chloride were refluxed in 150 mL of chlorobenzene for 2.5 hours.After cooling, the reaction solution was transferred to ice water and extracted three times with 250 mL of diethyl ether. The obtained extract was concentrated under reduced pressure and diethyl ether was distilled off to obtain 4.2 g of 2-bromo-5-hydroxybenzoic acid. 3.9 g of the obtained 2-bromo-5-hydroxybenzoic acid and 3.9 g of resorcinol (Tokyo Chemical Industry Co., Ltd.) were heated in 9 mL of 4 M NaOH aqueous solution at 60 ° C. for 30 minutes. 1.8 mL of a 10percent aqueous solution of copper sulfate was added to the reaction solution, followed by further heating at 80 ° C. for 10 minutes. The precipitate formed was recovered by filtration, and urineA white powder was obtained.
4.2 g With aluminum (III) chloride In chlorobenzene for 2.5 h; Reflux 5 g of 2-bromo-5-methoxybenzoic acid (manufactured by Wako Pure Chemical Industries, Ltd.)And 15 g of aluminum chloride were refluxed in 150 mL of chlorobenzene for 2.5 hours. After cooling, the reaction solution was transferred to ice water,Extraction was carried out three times using 250 mL of diethyl ether.The obtained extract was concentrated under reduced pressure, diethyl ether was distilled off,4.2 g of 2-bromo-5-hydroxybenzoic acid was obtained.3.9 g of the obtained 2-bromo-5-hydroxybenzoic acid and resorcinol3.9 g (manufactured by Tokyo Chemical Industry Co., Ltd.) was heated in 9 mL of 4 M NaOH aqueous solution at 60 ° C. for 30 minutes.1.8 mL of a 10percent aqueous solution of copper sulfate was added to the reaction solution, and further 80 ° C.,Heating was carried out for 10 minutes. The precipitate formed was collected by filtration,A white powder of Urolithin A was obtained.

Reference: [1] Yakugaku Zasshi, 1956, vol. 76, p. 1122,1125[2] Chem.Abstr., 1957, p. 3505
[3] Journal of Medicinal Chemistry, 2002, vol. 45, # 12, p. 2388 - 2409
[4] Patent: US5519133, 1996, A,
[5] Journal of Agricultural and Food Chemistry, 2008, vol. 56, # 2, p. 393 - 400
[6] Journal of Agricultural and Food Chemistry, 2009, vol. 57, # 21, p. 10181 - 10186
[7] Patent: WO2015/55736, 2015, A1, . Location in patent: Page/Page column 20
[8] Patent: EP2862568, 2015, A1, . Location in patent: Paragraph 0069
[9] Patent: JP2017/31108, 2017, A, . Location in patent: Paragraph 0084
[10] Patent: JP2017/7951, 2017, A, . Location in patent: Paragraph 0054
[11] Patent: JP2016/216378, 2016, A, . Location in patent: Paragraph 0056
[12] PLoS ONE, 2016, vol. 11, # 6,
[13] Patent: JP2017/14154, 2017, A, . Location in patent: Paragraph 0061
[14] Patent: JP2016/216443, 2016, A, . Location in patent: Paragraph 0063
  • 13
  • [ 67-56-1 ]
  • [ 22921-68-2 ]
  • [ 35450-36-3 ]
YieldReaction ConditionsOperation in experiment
85% for 18 h; Heating / reflux To a stirred solution of 2-bromo-5-methoxybenzoic acid (Aldrich 384003; 5.0 g, 21.6 mmol) in methanol (80 mL) was added concentrated hydrochloric acid (2 mL) and the mixture was heated under reflux for 18 hours. The resulting solution was cooled, the solvent was removed in vacuo, water (100 mL) was added and the mixture was extracted with ethyl acetate (2 x 100 mL). The combined extracts were washed with saturated aqueous sodium hydrogen carbonate, dried over MgSO4, filtered and evaporated to obtain methyl 2-bromo-5-methoxybenzoate as a light brown oil (4.50 g, 85percent); NMR Spectrum δH (300 MHz, CDCl3) 7.53 (1 H, d, J 8.8 Hz, 3-H), 7.32 (1 H, d, J 3.0 Hz, 6-H), 6.89 (1 H, dd, J 3.0, 8.8 Hz, 4-H), 3.94 (3 H, s, Ar OCH3) and 3.82 <n="66"/>(3 H, s, CO2CH3) (data in accordance with published values, see Barhate, N. B.; Gajare, A. S.; Wakharkar, R. D.; Bedekar, A. V. Tetrahedron 1999, 55, 11127- 11142); vmjcnfl (thin film) 2951, 1732 (C=O), 1592, 1472, 1433, 1289, 1250, 1227, 1099, 1017, 975, 823, 792 (data in accordance with published values, see Barhate, N. B.; Gajare, A. S.; Wakharkar, R. D.; Bedekar, A. V. Tetrahedron 1999, 55, 11127-11142.); Rf (hexane - ethyl acetate 5:1) 0.58.
Reference: [1] Tetrahedron, 1998, vol. 54, # 37, p. 11209 - 11234
[2] Journal of Organic Chemistry, 2003, vol. 68, # 11, p. 4586 - 4589
[3] Patent: WO2012/102985, 2012, A1, . Location in patent: Page/Page column 111
[4] Patent: WO2008/75048, 2008, A2, . Location in patent: Page/Page column 64-65
[5] Tetrahedron, 1995, vol. 51, # 37, p. 10115 - 10124
[6] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 17, p. 4601 - 4611
[7] Tetrahedron, 2016, vol. 72, # 24, p. 3454 - 3467
  • 14
  • [ 22921-68-2 ]
  • [ 35450-36-3 ]
Reference: [1] Yakugaku Zasshi, 1956, vol. 76, p. 1122,1125[2] Chem.Abstr., 1957, p. 3505
[3] Patent: US6514964, 2003, B1,
  • 15
  • [ 22921-68-2 ]
  • [ 74-88-4 ]
  • [ 35450-36-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 1, p. 222 - 227
  • 16
  • [ 75-91-2 ]
  • [ 22921-68-2 ]
  • [ 35450-36-3 ]
Reference: [1] Dalton Transactions, 2015, vol. 44, # 14, p. 6546 - 6559
[2] Journal of Organic Chemistry, 2013, vol. 78, # 19, p. 9898 - 9905
  • 17
  • [ 77152-08-0 ]
  • [ 22921-68-2 ]
  • [ 716-31-4 ]
Reference: [1] Journal of Organic Chemistry, 2013, vol. 78, # 22, p. 11126 - 11146
  • 18
  • [ 141-97-9 ]
  • [ 22921-68-2 ]
  • [ 19725-82-7 ]
Reference: [1] Patent: WO2006/67444, 2006, A1, . Location in patent: Page/Page column 64-65
  • 19
  • [ 22921-68-2 ]
  • [ 150192-39-5 ]
YieldReaction ConditionsOperation in experiment
100% With borane In tetrahydrofuran at 0 - 20℃; Dissolve 2-bromo-5-methoxy-benzoic acid (2.25 g, 9.7 mmol) in THF (10 mL) and cool to 0 [°C.] Add 1M borane in THF (48 mL, 48 mmol) and warm to room temperature. Upon completion, slowly pour reaction onto ice and saturated aqueous sodium bicarbonate. Extract with ethyl acetate and wash organic layer with water and saturated aqueous sodium bicarbonate. Dry with sodium sulfate, filter and concentrate in vacuo to yield 2.1 g (100percent) of the title [COMPOUND.APOS;H] NMR [(CDC13)] [O7.] 42 (d, J= 8.8 Hz, 1H), 7.06 (d, J = 3.1 Hz, 1H), 6.72 [(DD,] [J= 8.] 8,3. 1 Hz, [1H),] 4.71 (s, 2H), 3.81 (s, 3H).
96% With borane In tetrahydrofuran for 1 h; Under a nitrogen atmosphere, 25 g (0.11 mol) of 2-bromo-5-methoxybenzoic acid was dissolved in 100 mL of anhydrous THF. 140 mL (0.14 mol) of borane (1 M in THF) was added to this solution over a period of 1 hour. The reaction was allowed to stir and was carefully quenched with 1:1 THF: saturated K2CO3. Ether was added and the aqueous and organic layers were separated. The aqueous layer was extrated again with ether (2x100 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo to afford 23.0 g (96percent) of 2-bromo-5-methoxybenzyl alcohol (13). 1H NMR (CDCl3): 2.02 (t-1H; J=6.23 Hz), 3.79 (s-3H), 4.69 (d-2H; J=6.23 Hz), 6.70 (dd-1H; J=3.12, 8.72 Hz), 7.04 (d-1H; J=3.12 Hz), 7.39 (d-1H; J=8.72 Hz).
94%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran
Stage #2: at 60℃;
2-Bromo-5-methoxy benzoic acid (1 eq.) was dissolved in anhydrous THF (0.55M solution) and borane dimethylsulfide complex (2M in THF, 1 eq.) was added dropwise to the solution. The mixture was left stirring overnight, then HCl in MeOH was added and the mixture was warmed to 60 0C. All volatiles were evaporated and the residual material was dissolved in DCM. The solution was washed with IN HCl and with brine, then dried over Na2SO4 and evaporated in vacuo. A colorless oil was obtained (94percent), which was used without further characterization in the next reaction.
94%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran
Stage #2: With hydrogenchloride In tetrahydrofuran; methanol at 60℃;
2-Bromo-5-methoxy benzoic acid (1 eq) was dissolved in anhydrous TηF (0.55M solution) and BH3 SMe2 complex (2M in THF, 1 eq) was added dropwise to the solution. The mixture was stirred overnight, then HCl in MeOH was added and the mixture was warmed to 60 0C. All volatiles were evaporated and the residual material was dissolved in DCM. The solution was washed with IN HCl and with brine, then dried over Na2SO4 and evaporated in vacuo. A colorless oil was obtained (94percent), which was used without further characterization in the next reaction.
94% With dimethylsulfide borane complex In dichloromethane at 0 - 25℃; for 2 h; 18A (MW 231.05, 130 mmol, 30.0 g) in 300 mL CH2Cl2 at 00 C. Add BH3-SMe2 (3 equ, 25.2 mL) and age for 2 h at 250 C. Quench into aqueous 2 N HCl and separate layers. Dry organic (magnesium sulfate) and concentrate in vacuo to obtain 94percent yield of 18 (MW 217.06, 25.5 g).
96% With borane In tetrahydrofuran Preparation 9
2-bromo-5-methoxybenzyl alcohol (13)
Under a nitrogen atmosphere, 25 g (0.11 mol) of 2-bromo-5-methoxybenzoic acid was dissolved in 100 mL of anhydrous THF. 140 mL (0.14 mol) of borane (1 M in THF) was added to this solution over a period of 1 hour.
The reaction was allowed to stir and was carefully quenched with 1:1 THF: saturated K2CO3.
Ether was added and the aqueous and organic layers were separated.
The aqueous layer was extrated again with ether (2*100 mL).
The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo to afford 23.0 g (96percent) of 2-bromo-5-methoxybenzyl alcohol (13).
1H NMR (CDCl3): 2.02 (t-1H; J=6.23 Hz), 3.79 (s-3H), 4.69 (d-2H; J=6.23 Hz), 6.70 (dd-1H; J=3.12, 8.72 Hz), 7.04 (d-1H; J=3.12 Hz), 7.39 (d-1H; J=8.72 Hz).

Reference: [1] Patent: WO2004/9578, 2004, A2, . Location in patent: Page 31
[2] Journal of Organic Chemistry, 2005, vol. 70, # 2, p. 756 - 759
[3] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 149 - 162
[4] Journal of Organic Chemistry, 1993, vol. 58, # 17, p. 4579 - 4583
[5] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 17, p. 4511 - 4514
[6] Patent: US2004/77853, 2004, A1, . Location in patent: Page 25
[7] Patent: WO2007/129119, 2007, A1, . Location in patent: Page/Page column 43
[8] Patent: WO2009/10783, 2009, A1, . Location in patent: Page/Page column 45
[9] Patent: US6353110, 2002, B1, . Location in patent: Page column 25
[10] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4721 - 4736
[11] Journal of Organic Chemistry, 1999, vol. 64, # 26, p. 9658 - 9667
[12] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4447 - 4450
[13] Tetrahedron, 1998, vol. 54, # 37, p. 11209 - 11234
[14] Patent: WO2004/48314, 2004, A1, . Location in patent: Page 50-52
[15] Patent: US2003/87891, 2003, A1,
[16] Patent: US5807897, 1998, A,
[17] Patent: EP883599, 2002, B1,
[18] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 12, p. 3193 - 3195
[19] Journal of the American Chemical Society, 2011, vol. 133, # 20, p. 7916 - 7925
[20] Chemistry - An Asian Journal, 2018, vol. 13, # 17, p. 2401 - 2404
  • 20
  • [ 22921-68-2 ]
  • [ 54413-93-3 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 15, p. 4627 - 4631
  • 21
  • [ 22921-68-2 ]
  • [ 75534-35-9 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 20, p. 7916 - 7925
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 22921-68-2 ]

Aryls

Chemical Structure| 35450-36-3

[ 35450-36-3 ]

Methyl 2-bromo-5-methoxybenzoate

Similarity: 0.97

Chemical Structure| 88377-29-1

[ 88377-29-1 ]

2-Bromo-3-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 58380-11-3

[ 58380-11-3 ]

2-Bromo-5-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 28547-28-6

[ 28547-28-6 ]

2-Bromo-4-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 7507-86-0

[ 7507-86-0 ]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.89

Bromides

Chemical Structure| 35450-36-3

[ 35450-36-3 ]

Methyl 2-bromo-5-methoxybenzoate

Similarity: 0.97

Chemical Structure| 88377-29-1

[ 88377-29-1 ]

2-Bromo-3-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 58380-11-3

[ 58380-11-3 ]

2-Bromo-5-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 28547-28-6

[ 28547-28-6 ]

2-Bromo-4-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 7507-86-0

[ 7507-86-0 ]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.89

Ethers

Chemical Structure| 35450-36-3

[ 35450-36-3 ]

Methyl 2-bromo-5-methoxybenzoate

Similarity: 0.97

Chemical Structure| 88377-29-1

[ 88377-29-1 ]

2-Bromo-3-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 7507-86-0

[ 7507-86-0 ]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 1196474-68-6

[ 1196474-68-6 ]

Ethyl 4-(3-bromo-4-formylphenoxy)benzoate

Similarity: 0.89

Chemical Structure| 157893-14-6

[ 157893-14-6 ]

3-Bromo-5-methoxybenzoic acid

Similarity: 0.88

Carboxylic Acids

Chemical Structure| 88377-29-1

[ 88377-29-1 ]

2-Bromo-3-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 58380-11-3

[ 58380-11-3 ]

2-Bromo-5-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 28547-28-6

[ 28547-28-6 ]

2-Bromo-4-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 157893-14-6

[ 157893-14-6 ]

3-Bromo-5-methoxybenzoic acid

Similarity: 0.88

Chemical Structure| 56256-14-5

[ 56256-14-5 ]

4-Bromo-3-methoxybenzoic acid

Similarity: 0.88